


Launched in January 2010 fund after a successful five-year track record in institutional markets, the fund applies Sarasin's proven global thematic investment process to our universe of UK equities as a means of generating repeatable alpha and income growth.The fund seeks to achieve an annualised total return that is 1% in excess of the FTSE All Share (5% capped) benchmark on a rolling 3 year basis.
| Name | % Net Assets | 
|---|---|
| BP | 5.3% | 
| BG Group | 4.7% | 
| Xstrata | 4.1% | 
| BT | 4.0% | 
| BHP Billiton | 4.0% | 
| Petrofac | 3.8% | 
| HSBC Holdings | 3.5% | 
| AstraZeneca | 3.1% | 
| Barclays Bank | 2.8% | 
| GlaxoSmithKline | 2.3% | 
| Key | % Net Assets | 
|---|---|
| 5.3% | |
| 4.7% | |
| 4.1% | |
| 4.0% | |
| 81.9% | 
| Date | 08-Jun-2023 | 
|---|---|
| NAV | 88.37p | 
| Currency | GBP | 
| Change | -0.48p | 
| % | -0.54% | 
| YTD change | 88.37p | 
| YTD % | n/a | 
| Fund Inception | 28/01/2010 | 
|---|---|
| Fund Manager | n/a | 
| TER | 1.71 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research